Literature DB >> 15637757

Association of Fas-670 gene polymorphism with inflammatory bowel disease in Chinese patients.

Bing Xia1, Yu-Hong Yu, Qiu-Sha Guo, Xiang-Yin Li, Li Jiang, Jin Li.   

Abstract

AIM: Recent studies suggest that Fas-mediated apoptosis is involved in the pathogenesis of inflammatory bowel disease (IBD). It has been hypothesized that either increased apoptosis of intestinal epithelium or decreased apoptosis of lamina propria lymphocytes may induce inflammation of gut. The aim of this study was to determine whether the Fas gene promoter polymorphism at position-670 was associated with IBD in Chinese patients.
METHODS: Fifty unrelated Chinese patients with IBD (38 patients with ulcerative colitis and 12 with Crohn's disease) and 124 healthy controls were genotyped for the Fas-670 polymorphism by PCR-restriction fragment length polymorphism method. The PCR product was digested by Mva I restriction enzyme.
RESULTS: Distribution of the Fas-670 gene polymorphism was 33% for the AA genotype, 52% for the AG genotype and 15% for the GG genotype in 124 healthy subjects. In patients with IBD, 30% was for the AA genotype, 42% for the AG genotype and 28% for the GG genotype respectively. However, there was no significant difference in the genotype (P = 0.1498), allele frequencies (P = 0.3198) and carriage frequencies (P = 0.4133) between healthy controls and IBD patients. Furthermore, we did not find any difference between the left-sided colitis and total colitis (P = 0.8242).
CONCLUSION: Fas-670 polymorphism is not associated with IBD in Chinese patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637757      PMCID: PMC4205351          DOI: 10.3748/wjg.v11.i3.415

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

Review 1.  STATs find that hanging together can be stimulating.

Authors:  S Leung; X Li; G R Stark
Journal:  Science       Date:  1996-08-09       Impact factor: 47.728

2.  Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis.

Authors:  M Boirivant; R Pica; R DeMaria; R Testi; F Pallone; W Strober
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

3.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

Review 4.  Regulation of life and death in lamina propria T cells.

Authors:  A D Levine; C Fiocchi
Journal:  Semin Immunol       Date:  2001-06       Impact factor: 11.130

5.  Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis.

Authors:  U von Reyher; J Sträter; W Kittstein; M Gschwendt; P H Krammer; P Möller
Journal:  Cancer Res       Date:  1998-02-01       Impact factor: 12.701

6.  Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene.

Authors:  Q R Huang; D Morris; N Manolios
Journal:  Mol Immunol       Date:  1997-06       Impact factor: 4.407

7.  Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients.

Authors:  Q R Huang; V Danis; M Lassere; J Edmonds; N Manolios
Journal:  Rheumatology (Oxford)       Date:  1999-07       Impact factor: 7.580

Review 8.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

9.  Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats.

Authors:  Antonella Vetuschi; Giovanni Latella; Roberta Sferra; Renzo Caprilli; Eugenio Gaudio
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

10.  A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.

Authors:  Satomi Kanemitsu; Kenji Ihara; Ahmed Saifddin; Takeshi Otsuka; Tsutomu Takeuchi; Jun Nagayama; Michihiko Kuwano; Toshiro Hara
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

View more
  7 in total

1.  Association of Fas/Apo1 gene promoter (-670 A/G) polymorphism in Tunisian patients with IBD.

Authors:  Walid Ben Aleya; Imen Sfar; Leila Mouelhi; Houda Aouadi; Mouna Makhlouf; Salwa Ayed-Jendoubi; Samira Matri; Azza Filali; Taoufik Najjar; Taeib Ben Abdallah; Khaled Ayed; Yousr Gorgi
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

2.  Association of TNF-α and Fas gene promoter polymorphism with the risk of Kashin-Beck disease in Northwest Chinese population.

Authors:  Quan-ming Zhao; Xiong Guo; Jiang-hua Lai; Wu-hong Tan; Wei-zhuo Wang; Xiao-qian Dang
Journal:  Clin Rheumatol       Date:  2012-03-20       Impact factor: 2.980

3.  Epidemiology and gene markers of ulcerative colitis in the Chinese.

Authors:  Jun Yun; Chang-Tai Xu; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

4.  APO-1/Fas gene: Structural and functional characteristics in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Richa Singh; Vandana Pradhan; Manisha Patwardhan; K Ghosh
Journal:  Indian J Hum Genet       Date:  2009-09

5.  The role of FAS gene variants in inflammatory bowel disease.

Authors:  Ayhan Demir; Resul Kahraman; Gonca Candan; Arzu Ergen
Journal:  Turk J Gastroenterol       Date:  2020-05       Impact factor: 1.852

6.  On the genetic involvement of apoptosis-related genes in Crohn's disease as revealed by an extended association screen using 245 markers: no evidence for new predisposing factors.

Authors:  Sonja E N Wagenleiter; Peter Jagiello; Denis A Akkad; Larissa Arning; Thomas Griga; Wolfram Klein; Jörg T Epplen
Journal:  J Negat Results Biomed       Date:  2005-11-30

7.  Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma.

Authors:  Pei-Feng Liu; Yu-Chang Hu; Bor-Hwang Kang; Yu-Kai Tseng; Pi-Chuang Wu; Chi-Chuang Liang; Yu-Yi Hou; Ting-Ying Fu; Huei-Han Liou; I-Chien Hsieh; Luo-Ping Ger; Chih-Wen Shu
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.